| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Sep 17 | MPLAN | 108,493 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Sep 16 | MPLAN | 195,841 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Sep 15 | MPLAN | 95,666 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 17 | SPLAN | 6,802 | $64.95 | $442K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 17 | SPLAN | 101,691 | $64.59 | $6.6M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 17 | MPLAN | 108,493 | $23.34 | $2.5M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 16 | SPLAN | 96,125 | $63.64 | $6.1M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 16 | SPLAN | 99,716 | $63.26 | $6.3M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 16 | MPLAN | 195,841 | $23.34 | $4.6M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 15 | SPLAN | 270 | $65.31 | $18K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 15 | SPLAN | 3,102 | $63.64 | $197K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 15 | SPLAN | 28,796 | $62.66 | $1.8M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 15 | SPLAN | 63,498 | $61.99 | $3.9M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Sep 15 | MPLAN | 95,666 | $23.34 | $2.2M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | May 4 | MPLAN | 22,500 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | May 4 | APLAN | 45,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | May 6 | SPLAN | 22,500 | $43.95 | $989K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | May 4 | MPLAN | 22,500 | $0.00 | — |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 15 | SPLAN | 20 | $42.66 | $853 |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 15 | SPLAN | 7,165 | $41.75 | $299K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 15 | SPLAN | 56,815 | $41.01 | $2.3M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 13 | APLAN | 64,000 | $0.00 | — |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Apr 1 | MPLAN | 60,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 1 | SPLAN | 25,098 | $31.46 | $790K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 1 | SPLAN | 34,902 | $30.55 | $1.1M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Apr 1 | MPLAN | 60,000 | $15.46 | $928K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Feb 20 | MPLAN | 60,000 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Feb 20 | SPLAN | 60,000 | $30.10 | $1.8M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Feb 20 | MPLAN | 60,000 | $15.46 | $928K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Jan 31 | APLAN | 303,600 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Feb 3 | SPLAN | 33,635 | $32.70 | $1.1M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Feb 3 | SPLAN | 66,452 | $32.06 | $2.1M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Jan 31 | APLAN | 113,800 | $0.00 | — |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Jan 27 | MPLAN | 51,865 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEODERIV | Jan 23 | MPLAN | 8,135 | $0.00 | —? |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Jan 27 | SPLAN | 51,865 | $30.10 | $1.6M |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Jan 27 | MPLAN | 51,865 | $15.46 | $802K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Jan 23 | SPLAN | 8,135 | $30.01 | $244K |
| Travere Therapeutics, Inc. | TVTX | Eric M. DubeCEO | Jan 23 | MPLAN | 8,135 | $15.46 | $126K |